Lantheus Holdings, Inc. (LNTH) Stock Overview
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic
✓ Sourced directly from Yahoo Finance · Checked for accuracy at every rebuild · Snapshot: 6 September 2026
About Lantheus Holdings, Inc.
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in diagnosis and treatment of heart, cancer, and other diseases worldwide. The company offers DEFINITY, an injectable ultrasound enhancing agent used in echocardiography…
Source: Yahoo Finance
Sector & Industry
Lantheus Holdings, Inc. operates in the Healthcare sector, within the Drug Manufacturers - Specialty & Generic industry group. It is listed on the NASDAQ exchange.
Lantheus Holdings, Inc. at a Glance
| Company | Lantheus Holdings, Inc. |
| Ticker | LNTH |
| Exchange | NASDAQ |
| Currency | USD |
| Price | $100.97 |
| Market cap | $6.59B |
| P/E ratio (trailing) | 24.16 |
| EPS (trailing) | $4.18 |
| 52-week high | $111.86 |
| 52-week low | $49.67 |
| Dividend yield | — |
| Ex-dividend date | — |
| Beta | -0.03 |
| Return on equity (ROE) | 22.21% |
| Debt-to-equity | 47.64% |
| Average volume | 1.34M |
| Shares outstanding | 65.27M |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Employees | 1,193 |
| Country | United States |
Investing Essentials
As an Amazon Associate we earn from qualifying purchases. Links below are affiliate links.
Evaluating pharma pipelines, devices and healthcare economics.
Check Price →Peter Lynch on how everyday investors can spot winners before the professionals do.
Check Price →Benjamin Graham's classic on value investing — the book Warren Buffett calls the best ever written on the subject.
Check Price →Frequently Asked Questions
- What is Lantheus Holdings, Inc.'s current P/E ratio?
- Lantheus Holdings, Inc. (LNTH) has a trailing P/E ratio of 24.16 as of our 6 September 2026 data snapshot. Learn what the P/E ratio means →
- What is Lantheus Holdings, Inc.'s market capitalisation?
- Lantheus Holdings, Inc.'s market cap is $6.59B based on our latest snapshot. See how it ranks by market cap →
- What is LNTH's 52-week range?
- Over the past 52 weeks, LNTH has traded between $49.67 and $111.86. What does the 52-week range mean? →
- How volatile is Lantheus Holdings, Inc. compared to the market?
- Lantheus Holdings, Inc. has a beta of -0.03, meaning it has historically moved less than the broader market. What does beta measure? →
- Does Lantheus Holdings, Inc. pay a dividend?
- Lantheus Holdings, Inc. does not currently pay a dividend according to our latest data.
- What exchange is LNTH listed on?
- LNTH is listed on the NASDAQ. Browse all NASDAQ-listed stocks →
- What sector is Lantheus Holdings, Inc. in?
- Lantheus Holdings, Inc. is classified in the Healthcare sector. Compare with Healthcare peers →
For compound interest, percentage change and other investing maths, try our free online calculators.
Many readers keep a stock investing journal to log positions and theses alongside pages like this one, and a dedicated financial calculator to hand for quick valuation maths.
Recommended Reading & Tools
Burton Malkiel's evidence-based guide to markets, indexing and long-term strategy.
Check Price →Philip Fisher on what makes a business worth owning for the long term.
Check Price →Morgan Housel's short lessons on behaviour, luck and long-term wealth.
Check Price →